Related Experiment Video
Updated: May 22, 2026
An Experimental System to Study Mechanotransduction in Fetal Lung Cells
Published on: February 16, 2012
Clara cell protein expression in human neonates during respiratory distress syndrome
Joel Arias-Martínez1, Miguel Palacios-Sánchez, Dagoberto Delgado-Franco
1Departamento de Bioquímica y Biología Molecular, Instituto Nacional de Perinatología IER Mexico City, Mexico.
Insights
Clara cell protein (cc-10) levels and forms are altered in infants with infant respiratory distress syndrome (iRDS). This differential expression may impact its protective functions in the airways.
Area of Science:
- Neonatal Medicine
- Pulmonary Biology
- Biochemistry
Background:
- Clara cell protein (cc-10) has anti-inflammatory and surfactant-protective roles in the lungs.
- Recombinant cc-10 administration benefits infant respiratory distress syndrome (iRDS).
- Altered cc-10 expression may influence its protective functions.
Purpose of the Study:
- To characterize cc-10 expression in infants with iRDS.
- To investigate potential alterations in cc-10 structure and function.
Main Methods:
- Analysis of cc-10 in bronchotracheal aspirates from infants with iRDS and a control group.
- Utilized two-dimensional gel electrophoresis (2-DE) combined with immunoprecipitation and immunoblotting techniques.
Main Results:
- Seven cc-10 forms were detected in iRDS infants, compared to four in the control group.
- Lower overall cc-10 levels were observed in infants with iRDS.
- Differences in cc-10 isoform pattern and distribution were identified.
Conclusions:
- Differential expression of cc-10 in iRDS infants suggests a potential mechanism involving protein structure modification.
- Altered cc-10 may compromise its anti-inflammatory and surfactant-protective functions in iRDS.
- Findings could provide insights into the pathophysiology of this airway disorder.
Background/Aims:
Clara cell protein (cc-10) has been shown to negatively regulate inflammation, protect pulmonary surfactant from degradation in the lung, and administration of this recombinant protein improves the condition of infant respiratory distress syndrome (iRDS), a disease that occurred mainly in preterm infants. In view of the possibility that altered expression of cc-10 might regulate its protective function, we attempted to characterize this protein in infants with iRDS.
Methods:
Using bronchotraqueal aspirates from human infants, we analyzed cc-10 in two-dimensional gel electrophoresis (2-DE) by combining immunoprecipitation, carbonyl groups and total protein immunoblotting.
Results:
Seven forms of cc-10 were detected with western immunoblots in infants with iRDS while only four forms were present in neonates who needed mechanical ventilation for other reasons without any lung disease (control group). The overall levels of cc-10 in iRDS were lower and differences were seen in isoform pattern and distribution.
Conclusion:
Our demonstration that cc-10 is differentially expressed in infants with iRDS may point the way towards one possible mechanism that potentially involves modifications of the protein structure with its anti-inflammatory and surfactant protective function and could be detrimental for this airway disorder.
